cureosity_team

CUREOSITY Secures €3.8 Million Investment to Propel VR Therapy Innovations

In a significant stride towards revolutionizing therapeutic interventions, medtech innovator CUREOSITY has announced securing an additional €3.8 million in funding, catapulting its total investment to over €8.4 million. Specializing in the development of virtual reality (VR) therapy enhanced by gamification, CUREOSITY integrates cutting-edge neuroscientific discoveries, particularly harnessing the power of neuroplasticity, with decades of therapeutic…

Read More

Paradigm Health Secures $78M Series B to Embed Clinical Trials in Global Routine Healthcare

Paradigm Health has raised $78 million in an oversubscribed Series B round as the U.S. technology company accelerates its effort to embed clinical trials directly within routine patient care across the country and abroad. The investment was led by ARCH Venture Partners, joined by new backer DFJ Growth and returning investors including F-Prime, General Catalyst,…

Read More

With a $17 Million Series A, Estuary Aims to Crack the Data‑Bottleneck Holding Back Enterprise AI

In the most recent wave of enterprise‑infrastructure financing, Estuary has raised $17 million in a Series A round led by M13, with participation from FirstMark Capital and Operator Partners. This fresh capital is intended to accelerate the company’s ambition of transforming how large organisations move and synchronise data—specifically to enable so‑called “right‑time” pipelines that underpin analytics, operations and…

Read More

Mentium Raises $3.2M to Deploy AI-Powered Digital Workers, Poised to Revolutionize Freight Brokerage Operations

In the labyrinthine world of freight brokerage and logistics, inefficiency has long been the silent profit killer. Fragmented systems, labor-intensive back-office processes, and error-prone workflows have hamstrung growth and squeezed margins for decades. Enter Mentium, an AI-native startup that aims to disrupt this status quo with its pioneering platform of “digital workers” designed to automate…

Read More

Sonoma Biotherapeutics Secures $45 Million Milestone Payment from Regeneron in Transformative Collaboration

Sonoma Biotherapeutics, Inc., a leading clinical-stage biotechnology firm specializing in engineered regulatory T cell (Treg) therapies, has achieved a significant milestone with a $45 million payment from Regeneron Pharmaceuticals, Inc. This milestone underscores the fruitful partnership between the two companies in developing advanced treatments for autoimmune diseases. The payment marks a pivotal point in Sonoma…

Read More

Delta Data Unveils Enhanced Global Fee Management Solution

Delta Data, a leading provider of software solutions for the global mutual fund and pooled fund industry, has announced significant advancements to its Fee Management solution. These updates empower asset management firms to seamlessly manage intermediary fees across international jurisdictions, reinforcing Delta Data’s commitment to enhancing operational efficiency and global market accessibility. The enhanced functionality…

Read More

Tookitaki Secures Strategic Funding from True Global Ventures to Transform Financial Crime Prevention in Asia

In a significant move poised to reshape the landscape of financial crime prevention across Asia, True Global Ventures (TGV) has announced a strategic investment in Tookitaki, a leading provider of anti-financial crime software. This funding, coinciding with Tookitaki’s 10-year anniversary, aims to accelerate the company’s growth and innovation in response to the escalating regulatory demands…

Read More

Stream.Security Raises $30 Million to Revolutionize Cloud Security

In a significant stride toward enhancing cloud security, Stream.Security has successfully closed a $30 million Series B funding round. The round was led by U.S. Venture Partners, with participation from notable new investors like Citi Ventures and existing stakeholders including Energy Impact Partners, Cervin Ventures, TLV Partners, and Glilot Capital Partners. This latest funding brings…

Read More

Xanadu Selected for Canadian Quantum Champions Program, Eligible for Up to $23 Million in Federal Support

Xanadu Quantum Technologies Inc., a Canadian leader in photonic quantum computing, has been selected to participate in the newly launched Canadian Quantum Champions Program (CQCP)—a landmark federal initiative aimed at accelerating the development of fault-tolerant quantum computing and securing Canada’s long-term leadership in the sector. Through the program’s first phase, Xanadu Quantum Technologies Inc. is…

Read More

Noze Receives Historic $5M Investment from Bill & Melinda Gates Foundation to Advance Breath-Based Diagnostics

Noze, the innovative leader in breath-based diagnostic technology, has secured a transformative $5 million equity investment from the Bill & Melinda Gates Foundation. This groundbreaking funding is notable as it represents the Gates Foundation’s inaugural equity investment in a Canadian enterprise. The new investment, part of an extended funding round, builds on previous grants totaling…

Read More